Pamidronate

TERMINATED · PHASE1, PHASE2 · Osteoporosis

Inadequate eligible subjects to expect sufficient numbers to analyse outcomes.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.